Apple Inc (NASDAQ:AAPL)'s iPhone 15 hit the shelves today, generating extensive queues outside Apple Stores across major markets such as China, Europe, and the US.
This on-ground fervor echoes the robust online pre-order activity observed earlier, indicating a significant consumer appetite for the latest generation smartphone from Cupertino, analysts at Wedbush wrote.
BofA Securities analysts expect more investor attention to be drawn to Driven Brands Holdings Inc's winning combination of a roll-up story in a recovering/reopening auto aftermarket.
In an update to clients after attending the company’s analyst day, they noted that Driven Brands plans to reduce its near-term growth pace to fix current challenges and reduce debt.
Analysts at UBS are bullish on the web builder space as firms take advantage of the generative artificial intelligence (GenAI) opportunity, initiating coverage with a positive outlook on four sector leaders.
“GenAI is the next leg of the evolution of the web builder space, and near-term it should serve as a subscriber monetization tailwind as more/better tools are integrated into website editors and are reflected in higher subscription prices,” the analysts wrote in a note to clients.
Copper supply forecasts may be too optimistic, analysts at Jefferies believe.
In a note highlighting copper production growth, Jefferies believed that data indicates potential market deficits persisting until at least 2025.
Keurig Dr Pepper’s updated CEO succession plan should leave investors feeling comfortable, according to analysts at Barclays.
KDP told shareholders on Wednesday that Tim Cofer will be joining the company in November as its chief operating officer before transitioning into the CEO role in the second quarter of 2024.
Nutanix Inc (NASDAQ:NTNX) shares are down slightly Thursday, but analysts at Bank of America are bullish on the cloud computing company going forward.
The firm upgraded Nutanix stock to Buy with a price target of $50 (up from $39). The company’s shares traded 0.2% lower Thursday afternoon at $33.67.
Analysts at Bank of America (BofA) have raised their price target for FedEx (NYSE:FDX) after the transportation company delivered a first-quarter fiscal 2024 earnings beat.
They upped their price target on the ‘Buy’-rated stock from US$309 to US$311 based on their improved 2024 and 2025 fiscal year earnings per share estimates of $18.80 and $23.25 respectively.
The Upper Slope Fan System (Upper SFS) in 88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF)'s Project Phoenix is more extensive than initially mapped, according to a recent research note from Cavendish.
The newly completed mapping extends over four miles and correlates with strong oil potential, as evidenced by the Icewine-1 well, the corporate broker said.
Synairgen PLC (AIM:SNG, OTC:SYGGF) has reaffirmed its dedication to the clinical development of its primary respiratory anti-viral asset, SNG001, as revealed in its first-half financial results, according to analysts at Cavendish.
The phase III SPRINTER trial and the United States Government's ACTIV-2 trial have yielded valuable data, suggesting that SNG001 could potentially mitigate the progression of respiratory diseases, particularly in high-risk and severely affected patients, the corporate broker noted.
Supermarket Income REIT PLC (LSE:SUPR, OTC:SUPIF) has achieved a steady state following the unwinding of its Sainsbury’s Reversion Portfolio, Stifel analysts surmised following the investment vehicle’s Wednesday earnings call.
Analysts stated that “proceeds from the JV have been reinvested into a combination of earnings-accretive acquisitions and debt reduction such that we remain confident that next year's targeted 6.06p dividend will again be covered by earnings without the company having to make further acquisitions”.
Amazon.com Inc (NASDAQ:AMZN)'s plans to add 250,000 holiday employees this year is a move that signals optimism amidst increased costs, analysts at Bank of America have noted.
The expanded hiring strategy is a notable increase from the 150,000 hires made in the previous year, amidst a marked slowdown in North America quarter-to-quarter revenue growth.
UBS analysts reacted positively to Autozone Inc’s fourth-quarter 2023 earnings per share, which beat estimates driven by its gross margin strength despite what they believe were unfavorable weather conditions in certain regions that pressured the first half of the quarter.
In an update to clients, they noted that Autozone opened the majority of its mega hubs in the last few weeks of 4Q, which should help the aftermarket automotive parts and accessories retailer sustain share gains within the Do It For Me (DIFM) segment for an extended period while acting as a positive driver for the stock over time.
BofA Securities analysts have reduced their target price on The Walt Disney Company (NYSE:DIS) stock to $110 per share from $135 previously, while reiterating their ‘Buy’ rating, reflecting the transition underway for Disney and the media industry in general.
In an update to clients, they noted the company’s reduced target price is in line with Disney’s historical premium to the S&P 500.
The takeover of Round Hill Music Royalty Fund (LSE:RHMP, OTC:RHILF) is likely to be followed by more M&A activity in the sector, according to a new analysis of investment trust discounts.
Round Hill is one of what are called 'alternative' investment trusts, in contrast to their 'conventional' cousins that invested in listed equities.
Cybersecurity company CyberArk shares moved higher after analysts at Bank of America said the firm is poised to capitalize on the escalating importance of Privileged Access Management (PAM) in cybersecurity.
Over 80% of cyberattacks are attributed to identity exploitation, emphasizing the need for advanced identity security measures, especially focusing on privileged account identities.
Online gambling in the US continues to boom and with new players entering the industry all the time, analysts at Barclays believe that the top two market leaders are unlikely to lose their spots but that a battle for third place is likely over the coming years.
Updating its total addressable market (TAM) estimates to US$33 billion for the US industry in the medium term, Barclays PLC (LSE:BARC) expects this figure to jump to US$55 billion in the longer term, having incorporated Canada into predictions.
Boutique investment bank Liberum has raised its target price for logistics company Wincanton PLC (LSE:WIN, OTC:WNCNF) from 390p to 430p, reiterating its 'buy' recommendation.
The upgrade comes on the heels of a significant development in Wincanton's financial health.
Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) has successfully navigated the turbulent waters of biotech financing, securing £7.3 million from investors and leaving it with almost £10 million in the bank on 30 June.
Management has guided that the current cash reserves provide an operating cash runway into the first quarter of 2025.
Endava issued below expected financial year 2024 guidance as the technology company continues to be impacted by its outsized to Europe, FinTech and private equity and High Tech companies, analysts at Wedbush believe.
Endava, along with reporting its fourth quarter and full-year fiscal 2024 results before the opening bell on Tuesday, said it expects first quarter fiscal 2024 revenue in the range of £186 million (US$230.7 million) to £187 million (US$231.9 million), representing a constant currency decline between 2% to 1%.
Analysts at Stifel have reacted well to Trident Royalties PLC (AIM:TRR, OTCQX:TDTRF)’s latest earnings, which showed a 45% year-on-year rise in royalty receipts in the first six months of the year.
It was “an eventful period highlighted by multiple transactions”, said analysts, specifically the sale of Australia-based pre-production gold royalties and royalty acquisitions with associated milestone payments off Coeur Mining (NYSE:CDE).
Trinity Delta is highly optimistic about Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)'s recent phase II study results, predicting a 90% chance of success for the next phase of the evaluation.
The life sciences research house believes that the strong data effectively proves the concept of using Scancell's SCIB vaccine along with other cancer-fighting drugs. It also anticipates significant industry interest and sees potential for Scancell's vaccine to be used in broader applications.
Shares of Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) jumped 23% in early trading following the announcement that the initial stage of its phase II SCOPE trial in advanced melanoma has outperformed expectations.
The study focused on the effectiveness of Scancell's SCIB1 in combination with checkpoint inhibitors (CPIs). Preliminary data from 11 patients revealed an 82% objective response rate (ORR), notably exceeding the trial's initial target of a 70% ORR.
An upcoming antitrust lawsuit by the Federal Trade Commission (FTC) against Amazon.com Inc (NASDAQ:AMZN) will not likely bring about an outcome that materially alters the structure of the business, analysts at Wedbush believe.
According to recent media reports from publications including Bloomberg, the Wall Street Journal, and Politico, the FTC is preparing to file a lawsuit against the e-commerce giant as early as this month which will focus on several aspects of the Amazon marketplace.
Endava is expected to report higher revenue but lower earnings for the fourth quarter of fiscal 2023 when it hands down its latest financial results before the stock market opens on Tuesday, September 19.
For the quarter, Endava said it expects its revenue to be in the range of £187 million (US$231.9 million) to £189 million (US$234.3 million), representing constant currency revenue growth between 3% and 4%, and earnings per share (EPS) in the range of £0.44 (US$0.55) to £0.45 (US$0.56) per share.
House broker Shore Capital Markets responded positively to Touchstone Exploration Inc (AIM:TXP, TSX:TXP, OTC:PBEGF)’s “brief but very encouraging” production update on its recently commissioned Cascadura facility today.
Touchstone revealed that it achieved its forecasted Cascadura gross natural gas production rate of 60 million cubic feet per day (MMcf/d) on 15 September, which Shore Cap analysts said was “very consistent with our existing modelling assumptions”.
The past year has seen the pieces of the puzzle fall neatly into place for UK-based Futura Medical PLC (AIM:FUM, OTC:FAMDF), according to boutique investment bank, Liberum.
The company has successfully obtained US marketing authorisation and secured a US marketing partner, Haleon, for its erectile dysfunction (ED) treatment.
Shore Capital Markets anticipates a mixed bag of results when Supermarket Income REIT PLC (LSE:SUPR, OTC:SUPIF) announces its full-year earnings this Wednesday.
Earnings per share are expected to come in at 6p, a slight increase from 5.9p in 2022. This should result in a corresponding 6p dividend as forecast last September.